1Vogel I, Francksen H, Soeth E, et al. The carcinoembryonic antigen and its prognostic impact on immunocytologically detected intraperitoneal colorectal cancer cells. Am J Surg, 2001, 181: 188-193.
2Ford CH, Osbome PA, Rego BG, et al. Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen-expressing colon cancer cell lines in vitro and in vivo.Int J Cancer, 2001,92: 851-855.
3Flynn AA, Boxer GM, Begent RH, et al.Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images. Cancer Immunol Immunother,2001,50: 77-81.
4Holubec L, Jr Topolcan O, Pikner R, et al.The significance of CEA, CA19-9 and CA72-4 in the detection of colorectalcarcinoma recurrence. Anticancer Res,2000, 20: 5237-5244.
5Reiter W, Stieber P, Reuter C, et al.Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res. 2000,20: 5195-5198.
6Kem W, Beckert B, Lang N, et al. Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response. Anticancer Res,2000, 20: 4973-4975.
7Wichmann MW, Lau Wemer U, Muller C,et al. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.Anticancer Res, 2000, 20: 4953-4955.
8White SA, LoBuglio AF, Arani RB, et al.Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine. J Gene Med,2000, 2: 135-140.
9Yamana H, Itoh K. Specific immunotherapy with cancer vaccines. Gan To Kagaku Ryoho, 2000, 27: 1477-1488.
10Butler D, Maurice J, O'Brien C. Vaccines: a roller-coaster of hopes. Nature, 1997, 86:537-538.
1Chejfec G, Falkmer S, Askensten U, et al. Neu-roendocrine tumors of the gastrointestinal tract. Pathol Res Pract, 1988,183(2) :143.
2Gusturer F, Ueciuol P, Odd A, et al. Gastrointestinal carcinoids and carcinoid syndrome: classification, diagnosis and therapy. G Chir,1997,18(10) :514.
3Gould VE. The neuroendocrine cell system : Its tumors, typerplaias and dysplasias. Principl Pract Surg Pathol, 1983,14:1487.
4Soga J. Carcinoids of the small intestine:a statistical evaluation of 1102 cases collected from the literature. J Exp Clin Cancer Res, 1997,16(4) :353.
5Raju GC, Lee YS. Gastrointestinal carcinoid tumors : histological, histochemical and immuno-histochemical study. Ann Acad Med Singapore, 1988,17(1) : 81.
6Hamilton SR,Altonen LA.World Health Orgnization Classification of Tumors.Pathology and Genetics,Tumors of the Digestive System[M].Lyon:IARC Press,2000.53-58.
7Fujiyoshi Y,Kuhara H,Eimotoh T,et al.Composite glandular-endocrine cell carcinoma of the stomach.Report of two cases with goblet cell carcinoid component[J].Pathol Res Prac,2005,200 (11-12) h:823-829.
8Fossmark R,Martinsen TC,Qvigstad G,et al.Ultrastructure and chromogranin A immunogold labelling of ECL cell carcinoids[J].APMIS,2005,113(7-8):506-512.
9Portela-Gomes GM,Lukinius A,Grimelius L.Synaptic vesicle protein 2,A new neuroendocrine cell marker[J].Am J Pathol,2000,157 (4):1299-1309.
10Cohen T,Gluzman-Poltorak Z,Brodzky A,et al.Neuroendocrine cells along the digestive tract express neuropilin-2[J].Biochem Biophys Res Commun,2001,284(2):395-403.
